West Pharmaceutical Services, Inc.
WST
Classificação em ações
#879
West Pharmaceutical Services, Inc. (WST) specializes in the development,... West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Preço da ação
$389.10
Última sincronização: 2026-10-20
Valor de mercado
$27.38B
Variação (1 dia)
1.30%
Variação (1 ano)
39.27%
País
US
Negociar West Pharmaceutical Services, Inc. (WST)
Categoria
Healthcare
Rácio P/E de West Pharmaceutical Services, Inc. (WST)
Rácio P/E em October 2026 TTM: 47.60
De acordo com os últimos relatórios financeiros e o preço das ações da West Pharmaceutical Services, Inc., o rácio P/E atual (TTM) é 47.60. No final de 2023, a empresa tinha um P/E de 44.09.
Histórico do rácio P/E da West Pharmaceutical Services, Inc. de 2000 a 2026
Rácio P/E no final de cada ano
| Ano | Índice P/E | Alterar |
|---|---|---|
| 2026 (TTM) | 47.60 | -1.91% |
| 2024 | 48.53 | 10.08% |
| 2023 | 44.09 | 47.53% |
| 2022 | 29.89 | -43.32% |
| 2021 | 52.73 | -12.81% |
| 2020 | 60.48 | 31.40% |
| 2019 | 46.03 | 31.45% |
| 2018 | 35.01 | -27.64% |
| 2017 | 48.39 | 11.74% |
| 2016 | 43.30 | -4.53% |
| 2015 | 45.35 | 52.71% |
| 2014 | 29.70 | -2.33% |
| 2013 | 30.41 | 31.79% |
| 2012 | 23.07 | 36.16% |
| 2011 | 16.94 | -19.35% |
| 2010 | 21.01 | 18.63% |
| 2009 | 17.71 | 24.43% |
| 2008 | 14.23 | -24.20% |
| 2007 | 18.78 | -23.63% |
| 2006 | 24.59 | 43.98% |
| 2005 | 17.08 | -55.90% |
| 2004 | 38.72 | 151.44% |
| 2003 | 15.40 | -19.63% |
| 2002 | 19.16 | -126.13% |
| 2001 | -73.33 | -133.16% |
| 2000 | 221.15 | 0.00% |
Rácio P/E para empresas semelhantes ou concorrentes
| Empresa | Rácio P/E | Diferença do rácio P/E | País |
|---|---|---|---|
| 47.48 | -0.25% |
US
|
|
| 27.43 | -42.39% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 19.51% |
US
|
|
| - | - |
CH
|
Como interpretar um P/E Ratio?
O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.
Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.
Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.